![](https://phage.health/wp-content/uploads/2021/09/news2.png)
![](https://phage.health/wp-content/uploads/2021/09/full-shape-purple.png)
![](https://phage.health/wp-content/uploads/2023/01/eic.jpg)
Namur (Belgium), 13 January 2023
Vésale Bioscience is developing innovative precision phage therapy solutions to treat bacterial infections resistant to antibiotics, and today announces that it has received a €1.8 million grant from the European Innovation Council to accelerate the development of its diagnostic tool enabling personalized phage therapies.
More info via eric.poskin@phage.health, Spokesman – Corporate & Strategy Communication Director.